Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Matrix (Stuttgart, Germany)|July 1, 1993
Valyl-alanyl-prolyl-glycine (VAPG) serves as a quantitative marker for human elastinsL S Price, P J Roos, V P Shively, et al.Surgery|August 1, 1997
Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aortaN A Tamarina, W D McMillan, V P Shively, et al.The Journal of Surgical Research|July 29, 1999
Characterization of vascular gene transfer using a novel cationic lipidJ S Matsumura, R Kim, V P Shively, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|August 1, 1995
In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aortaW D McMillan, B K Patterson, R R Keen, et al.Journal of Vascular Surgery|January 1, 1997
Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aortaP K Shireman, W J McCarthy, W H Pearce, et al.Journal of Vascular Surgery|November 1, 1994
Interleukin-1 beta induces differential gene expression in aortic smooth muscle cellsR R Keen, K D Nolan, M Cipollone, et al.Journal of Vascular Surgery|August 1, 1992
Elastin content, cross-links, and mRNA in normal and aneurysmal human aortaB T Baxter, G S McGee, V P Shively, et al.Journal of Vascular Surgery|November 1, 1996
Plasminogen activator levels are influenced by location and varicosity in greater saphenous veinP K Shireman, W J McCarthy, W H Pearce, et al.Journal of Vascular Surgery|October 1, 1989
Collagen types and matrix protein content in human abdominal aortic aneurysmsR J Rizzo, W J McCarthy, S N Dixit, et al.Surgery|August 1, 1991
Aneurysm or occlusive disease--factors determining the clinical course of atherosclerosis of the infrarenal aortaG S McGee, B T Baxter, V P Shively, et al.Pageof 2